Market Overview

Why Grifols Is Trading Higher Today

Why Grifols Is Trading Higher Today

Grifols (NASDAQ: GRFS) shares are trading higher on Thursday. The company announced it's working with the U.S. biomedical advanced research development authority and the FDA to collect plasma from COVID-19 patients.

The plan is to determine if anti-SARS-CoV-2 hyperimmune globulin therapy can successfully be used to treat COVID-19 disease.

Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter.

Grifols is a Spanish multinational pharmaceutical and chemical manufacturer headquartered in Barcelona. The company is a producer of blood plasma-based products and supplies devices, instruments, and reagents for clinical testing laboratories.

Grifols ADR class B shares were trading up 9.34% at $19.43 on Thursday. The stock has a 52-week range between $25.73 and $13.40.


Related Articles (GRFS)

View Comments and Join the Discussion!

Posted-In: why it's movingBiotech News Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at